אנג'ריקס בי 20 מקג

Država: Izrael

Jezik: hebrejski

Izvor: Ministry of Health

Aktivni sastojci:

PURIFIED HEPATITIS B ANTIGEN

Dostupno od:

GLAXO SMITH KLINE (ISRAEL) LTD

ATC koda:

J07BC01

Farmaceutski oblik:

תרחיף להזרקה

Sastav:

PURIFIED HEPATITIS B ANTIGEN 20 MCG / 1 ML

Administracija rute:

תוך-שרירי

Tip recepta:

מרשם נדרש

Proizveden od:

GLAXO SMITH KLINE BIOLOGICALS S.A

Terapijska grupa:

HEPATITIS B, PURIFIED ANTIGEN

Područje terapije:

HEPATITIS B, PURIFIED ANTIGEN

Terapijske indikacije:

Active immunization against Hepatitis B virus.

Datum autorizacije:

2020-08-31

Uputa o lijeku

ʯʥʬʲ
ʯʫʸʶʬ
ʩʴʬ
ʺʥʰʷʺ
ʭʩʧʷʥʸʤ
)
ʭʩʸʩʹʫʺ (
ʮʹʺʤ
"
ʥ
‒
1986
ʤʴʥʸʺʤ
ʺʷʥʥʹʮ
ʬʲ
ʩʴ
ʭʹʸʮ
ʠʴʥʸ
ʣʡʬʡ
ʢʰʠ
'
ʱʷʩʸ
ʩʡ
20
ʷʮ
"
ʢ
ʳʩʧʸʺ
ʤʷʸʦʤʬ
ʬʫ
ʤʰʮ
)
1
ʮ
"
ʬ
(
ʤʬʩʫʮ
:
ʯʢʩʨʰʠ
ʬʹ
ʱʩʨʩʨʴʤ
B
20
ʷʮ
"
ʢ
(Purified hepatitis B antigen)
ʢʰʠ
'
ʱʷʩʸ
ʩʡ
10
ʷʮ
"
ʢ
ʳʩʧʸʺ
ʤʷʸʦʤʬ
ʬʫ
ʤʰʮ
)
0.5
ʮ
"
ʬ
(
ʤʬʩʫʮ
:
ʯʢʩʨʰʠ
ʬʹ
ʱʩʨʩʨʴʤ
B
10
ʷʮ
"
ʢ
(Purified hepatitis B
antigen)
ʺʮʩʹʸʬ
ʤ
ʭʩʸʮʥʧ
ʤ
ʩʺʬʡ
ʭʩʬʩʲʴ
ʭʩʩʰʢʸʬʠʥ
ʸʩʹʫʺʡ
,
ʤʠʸ
ʳʩʲʱ
2
‒
"
ʲʣʩʮ
ʡʥʹʧ
ʬʲ
ʷʬʧ
ʭʩʡʩʫʸʮʤʮ
ʬʹ
ʤʴʥʸʺʤ
"
ʳʩʲʱʥ
6
‒
"
ʲʣʩʮ
ʳʱʥʰ
."
ʠʸʷ
ʯʥʩʲʡ
ʺʠ
ʯʥʬʲʤ
ʣʲ
ʥʴʥʱ
ʭʸʨʡ
ʹʮʺʹʺ
ʤʴʥʸʺʡ
.
ʯʥʬʲ
ʤʦ
ʬʩʫʮ
ʲʣʩʮ
ʩʺʩʶʮʺ
ʬʲ
ʤʴʥʸʺʤ
.
ʭʠ
ʹʩ
ʪʬ
ʺʥʬʠʹ
ʺʥʴʱʥʰ
,
ʤʰʴ
ʬʠ
ʠʴʥʸʤ
ʥʠ
ʬʠ
ʧʷʥʸʤ
.
ʤʴʥʸʺ
ʥʦ
ʤʮʹʸʰ
ʪʸʥʡʲ
.
ʬʠ
ʸʩʡʲʺ
ʤʺʥʠ
ʭʩʸʧʠʬ
.
ʠʩʤ
ʤʬʥʬʲ
ʷʩʦʤʬ
ʭʤʬ
ʥʬʩʴʠ
ʭʠ
ʤʠʸʰ
ʪʬ
ʩʫ
ʭʡʶʮ
ʩʠʥʴʸʤ
ʤʮʥʣ
.
1
.
ʤʮʬ
ʺʣʲʥʩʮ
ʤʴʥʸʺʤ
?
ʢʰʠ
'
ʱʷʩʸ
ʩʡ
ʰʩʤ
ʥ
ʯʥʱʩʧ
ʬʩʲʴ
ʹʮʹʮʤ
ʣʢʰʫ
ʭʥʤʩʦ
ʡ
ʣʡʫ
)
ʺʡʤʶ
(
ʭʸʢʰʹ
ʬʲ
ʩʣʩ
ʱʥʸʩʥ
ʱʩʨʩʨʴʤ
ʢʥʱʮ
B
.
ʢʰʠ
'
ʱʷʩʸ
ʩʡ
20
ʷʮ
"
ʢ
ʯʥʱʩʧʤ
ʣʲʥʩʮ
ʭʩʸʢʥʡʮʬ
ʭʩʸʢʡʺʮʬʥ
ʬʩʢʮ
16
ʭʩʰʹ
ʤʬʲʮʥ
.
ʢʰʠ
'
ʱʷʩʸ
ʩʡ
10
ʷʮ
"
ʢ
ʯʥʱʩʧʤ
ʣʲʥʩʮ
ʺʥʷʥʰʩʺʬ
ʥʣʬʥʰʹ
,
ʬ
ʭʩʣʬʩ
ʥ
ʭʩʸʢʡʺʮ
ʣʲ
ʬʩʢ
15
ʭʩʰʹ
)
ʬʬʥʫ
ʬʩʢ
15
ʭʩʰʹ
(
.
ʱʩʨʩʨʴʤ
B
ʠʩʤ
ʤʬʧʮ
ʺʩʮʥʤʩʦ
ʬʹ
ʣʡʫʤ
ʺʮʸʢʰʤ
ʬʲ
ʩʣʩ
ʱʥʸʩʥ
.
ʹʩ
ʭʩʹʰʠ
ʭʴʥʢʡʹ
ʭʩʩʷ
ʱʥʸʩʥʥʤ
ʭʸʥʢʤ
ʺʬʧʮʬ
ʱʩʨʩʨʴʤ
B
ʭʤʥ
ʠʬ
ʭʩʬʥʫʩ
ʸʨʴʩʤʬ
ʥʰʮʮ
.
ʭʤ
ʯʩʩʣʲ
ʭʩʬʥʫʩ
ʷʩʡʣʤʬ
ʭʩʹʰʠ
ʭʩʸʧʠ
ʭʤʥ
ʭʩʸʣʢʥʮ
ʭʩʠʹʰʫ
.
ʤʬʧʮʤ
ʺʨʹʴʺʮ
ʬʲ
�